Integrating Unani Medicine in the Management of Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM) is a prevalent chronic condition that poses significant health challenges globally. Despite advances in conventional medicine, managing T2DM remains complex, with patients often experiencing side effects from long-term pharmaceutical treatments. Unani medicine, a traditional system with roots in ancient Greek and Islamic healing practices, has garnered attention for its potential role in managing type 2 diabetes mellitus (T2DM). Unani therapies focus on balancing the body's humours—blood, phlegm, yellow bile, and black bile—using natural remedies derived from herbs, minerals, and animal products. These formulations aim to regulate blood sugar levels, enhance insulin sensitivity, and address the underlying causes of diabetes, such as metabolic imbalances and inflammation. Key Unani herbs, such as Jamun (Syzygium cumini), Methi (Trigonella foenum-graecum), and Karela (Momordica charantia), are noted for their hypoglycemic and anti-inflammatory properties. Additionally, Unani dietary guidelines emphasise the importance of a balanced diet, regular exercise, and maintaining overall bodily harmony, complementing pharmacological interventions. Preliminary clinical studies and anecdotal evidence suggest that Unani medicine may offer a promising adjunctive therapy, enhancing glycemic control, reducing complications, and improving the quality of life for patients with type 2 diabetes mellitus (T2DM).